SFDA
-
HTDS: MMR Vaccine Passes Chinese SFDA Drug Evaluation
Hard to Treat Diseases (HTDS) and its China subsidiary Mellow Hope have announced that the MMR vaccine (Measles, Mumps and Rubella Combined Vaccine Live) has obtained a "pass" on its First Drug Evaluation. The Chinese State Food and Drug Administ…
SFDA | 14 January 2010
-
Sinovac Files Clinical Trial Application for HFMD in China
Sinovac Biotech, a provider of biopharmaceutical products in China, has filed an application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes …
SFDA | 07 January 2010
-
Sinovac Files Clinical Trial Application for HFMD in China
Siinovac Biotech, a provider of biopharmaceutical products in China, has filed the application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which caus…
SFDA | 01 January 2010
-
Tianyin Pharmaceutical Receives Approval from SFDA
Tianyin Pharmaceutical, a manufacturer and supplier of modernized traditional Chinese medicine based in Chengdu, China, has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liqui…
SFDA | 01 January 2010
-
DIA to Host First China Annual Meeting
The Drug Information Association (DIA), in collaboration with the China Center for Pharmaceutical International Exchange of the State Food and Drug Administration (SFDA), will host the First China Annual Meeting: Drug Development in a Flat World—In…
SFDA | 21 October 2009
-
Sinovac Obtains Production License for H1N1 Vaccine
Sinovac Biotech has announced that the State Food and Drug Administration (SFDA) has approved the registration application for Panflu.1, a H1N1 vaccine, and has issued a production license for this vaccine. Following results which showed that the …
SFDA | 09 September 2009
-
China Pharma Holdings: SFDA Approval for Clinical Trials
China Pharma Holdings has received official approval from China's State Food and Drug Administration (SFDA) to enter Phase I and Phase II clinical trials to test the efficacy of its cholesterol-lowering drug, Rosuvastatin. The company plans to be…
SFDA | 29 June 2009
-
Chinese SFDA Approves Laonian Kechuan Tablet Production
Chengdu-based Tianyin Pharmaceutical, a manufacturer and supplier of modernized traditional Chinese medicine (TCM), has received approval from the Chinese State Food and Drug Administration (SFDA) to produce Laonian Kechuan tablets in dosages of 0.2…
SFDA | 01 October 2008
-
Indian company receives USFDA approval for generic mitoxantrone
Dabur Pharma Ltd., India's leading oncology player, said the US Food and Drug Administration has granted final approval to the company's abbreviated new drug application to market it's generic version of EMD Serono's Novantrone (Mitoxantrone Hydrochl…
SFDA | 12 June 2008
-
USFDA: Tentative Approval For Generic Depakote Delayed Release Tablets
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) for generic Depakote, divalproex sodium delayed release tablets. Divalproex sodium delayed release t…
SFDA | 05 March 2008
